Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1. Crinetics granted 105,100 stock options and 9,950 RSUs to new employees. 2. Awards under the 2021 Inducement Plan support talent acquisition. 3. Stock options have an exercise price of $36.53, equal to current stock price. 4. The vesting period for options and RSUs is four years. 5. Crinetics focuses on development of treatments for endocrine diseases.